Abstract Abstract
Transthoracic echocardiography (TTE) is the most accessible noninvasive diagnostic procedure for the initial assessment of pediatric pulmonary hypertension (PH). This review focuses on principles and use of TTE to determine morphologic and functional parameters that are also useful for follow-up investigations in pediatric PH patients. A basic echocardiographic study of a patient with PH commonly includes the hemodynamic calculation of the systolic pulmonary artery pressure (PAP), the mean and diastolic PAP, the pulmonary artery acceleration time, and the presence of a pericardial effusion. A more detailed TTE investigation of the right ventricle (RV) includes assessment of its size and function. RV function can be evaluated by RV longitudinal systolic performance (e.g., tricuspid annular plane systolic excursion), the tricuspid regurgitation velocity/right ventricular outflow tract velocity time integral ratio, the fractional area change, tissue Doppler imaging–derived parameters, strain measurements, the systolic-to-diastolic duration ratio, the myocardial performance (Tei) index, the RV/left ventricle (LV) diameter ratio, the LV eccentricity index, determination of an enlarged right atrium and RV size, and RV volume determination by 3-dimensional echocardiography. Here, we discuss the potential use and limitations of TTE techniques in children with PH and/or ventricular dysfunction. We suggest a protocol for TTE assessment of PH and myocardial function that helps to identify PH patients and their response to pharmacotherapy. The outlined protocol focuses on the detailed assessment of the hypertensive RV; RV-LV crosstalk must be analyzed separately in the evaluation of different pathologies that account for pediatric PH.
Keywords: children, pulmonary hypertension, right ventricle
Pulmonary hypertension (PH) is a rare disease of the cardiopulmonary system that can be diagnosed at any age. PH can occur either as an idiopathic disease process (iPH) or secondary to other disease processes. Early evidence for the epidemiology of PH originated from adult registries; however, several newer pediatric international registries have contributed to our understanding of the disease in children as well.1-5 Pediatric PH can be associated with a variety of underlying conditions, including congenital heart disease (CHD), connective-tissue disorders, pulmonary disease, and endocrine, metabolic, and infectious diseases such as HIV. PH is usually progressive from infancy to adulthood and associated with poor prognosis.4 The recent World Symposium on Pulmonary Hypertension updated the clinical classification of PH to include several features related to pediatric PH.6 In children, pulmonary arterial hypertension (PAH; i.e., group 1 PAH of the Nice classification of 20136) is usually a severe, refractory, and lifelong disease. An international registry showed that about 57% of children had iPH, a proportion similar to that observed in adults.4,7 PH associated with CHD (PH-CHD) is more frequent in children (36%) than in adults (10%),4 while other associated forms are uncommon in children.8 For the initial assessment and follow-up of children with suspected or confirmed PH, transthoracic echocardiography (TTE) is the noninvasive diagnostic method of choice.5,9-11 TTE allows a detailed description of cardiovascular anatomy, ventricular function, and flow determination and carries low risk and wider availability, compared with cardiac magnetic resonance imaging (MRI). The diagnostic accuracy for describing cardiac morphology is high, with a reported incidence of less than 100 errors in more than 50,000 echocardiograms.12 With TTE,13 and MRI as well,14 the effects of growth (e.g., changes of age-dependent normal reference values) must be accounted for in the interpretation of different variables. Many functional variables were developed and validated for the assessment of the normal left ventricle (LV). However, normal right ventricle (RV) hemodynamic function is physiologically distinct from that of the LV, including differences in fiber arrangement,15 lower RV afterload, and lower RV pressures, compared to the LV.
Here, we review the principles and applications of TTE in patients with PH. The pathophysiology of PH includes abnormal pressure elevation in the RV, leading to flattening of the interventricular septum, with the LV appearing D-shaped. The LV has reduced systolic and diastolic volumes but usually preserved global systolic function.16 Although not the focus of this review, evaluation of the left heart, including LV systolic function (LV ejection fraction [EF], fractional shortening), longitudinal systolic LV function (mitral annular plane systolic excursion), and inflow and outflow Doppler of all valves, should be an integral part of the echocardiographic assessment of PH, to assess detrimental RV-LV interactions.17 After the initial diagnostic evaluation for PAH, TTEs are usually performed at 6–12-month intervals and when there is a clinical change. TTE assessment of RV function is commonly known to be technically difficult in both children and adults. The anterior position of the RV in the chest limits TTE visualization. Moreover, the RV has a complex geometry, with a triangular shape in the sagittal plane and a more crescent shape in the coronal plane. The RV inflow and outflow tracts are difficult to image simultaneously with 2-dimensional (2D) and Doppler echocardiography. In the standard apical 4-chamber view, the RV is usually smaller than the LV. To optimize imaging of the RV lateral wall, the 4-chamber image may have to be modified. RV dimensions are best estimated from an RV-focused apical 4-chamber view,18 although M-mode and 2D measurements of RV end-diastolic dimensions toward the outflow can be made in the parasternal views. From the apical position, to avoid underestimating the minor distance of the RV, the transducer is rotated rightward until the maximum diameter is obtained. To avoid overestimation, the transducer should be positioned over the cardiac apex, with the plane through the mid-LV. Care should be taken to obtain the maximum RV diameter without foreshortening the image. This can be accomplished by ensuring that the crux and apex of the heart are both visible. As part of its guidelines on chamber quantification, the American Society of Echocardiography (ASE) published recommendations for RV assessment in adults.18 Practical recommendations and a proposed protocol on the use of TTE variables to assess PH are available for the adult population.9,19,20 An echocardiographic study of a child with a suspected PH should include the assessment of the following variables: estimation of the systolic pulmonary artery pressure (PAP), by estimating right ventricular systolic pressure (RVSP) through the measurement of the maximal velocity of the tricuspid regurgitation (TR) jet by continuous-wave (CW) Doppler; estimation of mean PAP and end-diastolic PAP through CW Doppler velocity measurement of the pulmonary regurgitation (PR) jet in the parasternal short-axis (PSAX) view; RV longitudinal systolic function determination; RV strain and strain rate measurements; RV volume determination by 3-dimensional (3D) echocardiography; measurement of the RV systolic-to-diastolic duration ratio; determination of tissue Doppler velocities; measurement of the RV/LV diameter ratio and eccentricity index; and determination of the pulmonary artery (PA) acceleration time. The presence of a persistent ductus arteriosus (PDA) should be carefully evaluated in each child with PH so that the immediate or long-term option of PDA stenting in advanced pediatric pulmonary hypertensive vascular disease with near-systemic PAP is not missed (e.g., an “interventional ductal Potts shunt” procedure21,22).
However, interpretation of pediatric values is dependent on age and cardiac growth. Current pediatric recommendations will assist with this matter, although age- or body dimension–corrected z-scores are still lacking for many parameters.23 Although recent studies supported the potential value of echocardiography as a tool in guiding management in children with PH,24,25 there is still a knowledge gap in recommended use of TTE in pediatric PH patients.
Nevertheless, we aim to propose a pediatric imaging protocol for use of TTE for the initial diagnosis, follow-up, and treatment assessment of children with PH; a TTE study of a child with a suspected PH should include the assessment of all the variables shown in Table 1. The TTE variables, as well as their advantages and disadvantages, are shown in Tables 2 and 3.
Table 1.
Variables to be assessed |
---|
Estimation of the systolic PAP, through the TR jet velocity by CW Doppler |
Estimation of mean PAP and end-diastolic PAP through CW Doppler of the PR jet |
Pulmonary artery acceleration time (PAAT) |
RV longitudinal systolic function (e.g., TAPSE) |
RV fractional area change |
RV strain and strain rate measurements |
RV systolic to diastolic duration ratio by CW Doppler of the TR jet |
Tissue Doppler velocities (e.g., S′) |
RV myocardial performance (Tei) index |
RV/LV diameter ratio |
Left ventricular eccentricity index (LV EI) |
RV and RA enlargement |
TTE alone is not sufficient to initiate a targeted therapy. CW: continuous-wave; LV: left ventricle; PAP: pulmonary artery pressure; PH: pulmonary hypertension; PR: pulmonary regurgitation; RA: right atrium; RV: right ventricle; S′: peak systolic velocity; TAPSE: tricuspid annular plane systolic excursion; TR: tricuspid regurgitation; TTE: transthoracic echocardiography; 3D: 3-dimensional.
Table 2.
Variables | Interpretation | Initial | Follow-up |
---|---|---|---|
Systolic PAP (sPAP), mmHg | Bernoulli equation (dP = 4 × TRV2); TRV used to estimate sPAP; sPAP > 50 mmHg at rest makes PH highly likely in adults | Yes | Yes |
Mean PAP (mPAP), mmHg | Estimated mPAP = maximum PR velocity + mean RAP; pediatric PH defined as mPAP > 25 mmHg and PVRi > 3.0 WU m2 | Yes | Yes |
Diastolic PAP (dPAP), mmHg | Estimated dPAP = minimal (end-diastolic) PR velocity + mRAP; dPAP is independent of RV stroke volume | Yes | Yes |
PAAT, ms | PAAT < 100 ms: high probability of PH in adults | Yes | Yes |
TAPSE, mm | Decreased in advanced PH with RV dysfunction in children | Yes | Yes |
RV FAC, % | Impaired RV FAC = decreased systolic RV function in adults | Probably | Probably |
Strain, %; SR, s−1 | PH patients may have impaired longitudinal strain and strain rate at the RV free wall; strain and SR are frequently altered in severe PH | If available | If available |
S/D ratio | Ratio > 1.4 inversely correlates with survival in children with PH | Yes | Probably |
TDI (S′), cm/s | Decreased in advanced adult and pediatric PH; impaired S′ (measured in TDI, lateral RV wall) predicts adverse outcome | Yes | Yes |
Tei index | Increased index predicts RV dysfunction in pediatric PH | Yes | Probably |
RV/LV ratio | RV/LV ratio > 1 = increased adverse-event risk in pediatric PH | Yes | Yes |
LV EI | LV EI > 1 in adult PH-impaired RVx of the pressure-loaded RV | Yes | Yes |
RV/RA dilation | RV and RA area increase in adult PH; pediatric data missing | Yes | Yes |
dP: pressure gradient; EI: eccentricity index; FAC: fractional area change; LV: left ventricle; PAAT: pulmonary artery acceleration time; PAP: pulmonary artery pressure; PH: pulmonary hypertension; PR: pulmonary regurgitation; PVRi: pulmonary vascular resistance index; RA: right atrium; RAP: right atrial pressure; RV: right ventricle; RVx: right ventricular function; S′: peak systolic velocity; S/D ratio: systolic/diastolic duration ratio; SR: strain rate; TAPSE: tricuspid annular plane systolic excursion; TDI: tissue Doppler imaging; TR: tricuspid regurgitation; TRV: TR jet velocity; WU: Wood units.
Table 3.
Variable | Main advantages | Main disadvantages |
---|---|---|
Systolic PAP (sPAP) | Easily to perform; is known to be of significant prognostic value for PH | Depends of angle of CW Doppler interrogation; sPAP may be under/overestimated (severe TR) |
Mean PAP | At times better angle via PR than via TR | PR required for PR velocity measurements |
Diastolic PAP | Independent of RV systolic function | PR required for PR velocity measurements |
PAAT | Can be measured in most of the patients; PH likely if PAAT < 100 ms | Possible pulmonary valve artifacts; heart rate–dependent measure |
PE | Sign of heart failure | No pediatric data available |
TAPSE | Easily to perform; impaired RV function at values <2 SD of age-related values | Does not take into account segmental or radial RV function and contractility |
FAC | Decreased FAC = impaired RV function | High inter- and intraobserver variability |
Strain, strain rate | Regional deformation provides information on regional myocardial dysfunction; impaired RV longitudinal strain (<−12.5%) = greater PH severity | Relatively low temporal resolution that hinders tracking in the presence of high heart rates; strain and strain rate require a significant amount of postprocessing time |
S/D ratio | PH likely if S/D duration ratio > 1.4 | Requires presence of defined TR onset/end |
TDI (S′) | Easy to perform; decreased in adult and in pediatric PH patients | Variability with different loading conditions, assessment of motion in a single dimension |
Tei index | A combined ventricular-vascular index and independent of ventricular geometry | Systolic and diastolic time interval in a single index, no distinction between systolic/diastolic dysfunction |
RV/LV ratio | Easily obtained in the clinical setting; PH likely if ratio > 1 | Cannot be used in PH patients with significant left-to-right shunt lesions |
LV EI | Adverse outcome in adult PH if LV EI > 1 | Off-axis images; maybe artificially flattened septum |
RV/RA measures | Commonly used and simple; allows to indicate RV/RA enlargement | Normative values in children only for RV, not RA; interatrial septal bowing may have an influence |
CW: continuous-wave; EI: eccentricity index; FAC: fractional area change; LV: left ventricle; PAAT: pulmonary artery acceleration time; PAP: pulmonary artery pressure; PE: pericardial effusion; PH: pulmonary hypertension; PR: pulmonary regurgitation; RA: right atrium; RV: right ventricle; S/D ratio: systolic/diastolic duration ratio; S′, peak systolic velocity; TAPSE: tricuspid annular plane systolic excursion; TDI: tissue Doppler imaging; TR: tricuspid regurgitation.
Hemodynamic assessment of the RV
Estimation of PAP
Systolic PAP
The estimation of the systolic PAP (sPAP) is based on the peak velocity of the TR jet (TRV). The simplified Bernoulli equation using CW Doppler to assess the TRV (peak pressure; RVSP = sPAP = 4 × (TRV)2 + RA v-wave ≈ 4 × (TRV)2 + mean RAP, where RA is right atrium and RAP is right atrial pressure) describes the relationship of TR and RVSP as a surrogate of sPAP in the absence of RV outflow tract (RVOT) obstruction, pulmonary valve stenosis, or PA stenosis. Other formulas, such as the linear regression-derived sPAP = 1.07 × (4TRV + RAP) + 7.4, could also be reliable when estimating echocardiographically determined sPAP in PH patients.26 The RAP can be estimated on the basis of the diameter and respiratory variation of the inferior vena cava (IVC), although in pediatric clinical practice a value from 5 to 10 mmHg is mostly assumed. Usually, TRV values in adults above 3.4 m/s, corresponding to an sPAP > 50 mmHg at rest, indicate PH in adults with relatively high degree of certainty.
A limitation is that in cases with moderate to severe TR, the RVSP may be underestimated. Underestimation of the RVSP and therefore the sPAP may also occur because of a suboptimal Doppler insonation angle or an inadequate Doppler spectral envelope. Overestimation may occur because of measurement outside the modal velocity of the spectral envelope, overgaining the Doppler signal, or if pulmonary valve stenosis is present. In the presence of a ventricular septal defect with LV-to-RA shunts, sonographers should be careful to not misinterpret the LV-to-RA jet as a TR signal. Figure 1a demonstrates an example of increased TR jet velocity suggesting increased sPAP.
Mean PAP and diastolic PAP
If PR is measured with CW Doppler, then mean and disatolic PAP (mPAP and dPAP, respectively) can be estimated from the maximum (early-diastolic) and minimum (end-diastolic) PR velocity (PRV), respectively, with the simplified Bernoulli equation (mPAP = 4 × (maximum diastolic PRV)2 + RA v-wave = 4 × (PRV)2 + mean RAP; dPAP = 4 × (maximum diastolic PRV)2 + RA v-wave = 4 × (minimum end-diastolic PRV)2 + mRAP).27 This enhances Doppler estimation of PAP and thus diagnosis of potential PAH, applying the accepted definition of pediatric PAH as mPAP > 25 mmHg with a pulmonary vascular resistance (PVR) index > 3.0 Wood units m2 for biventricular circulations.28 The mPAP and dPAP can be estimated, using CW Doppler of the PR jet in the PSAX view, by measurement of the peak and minimal diastolic velocities. Mean PAP and dPAP are not routinely used in the diagnosis and follow-up of pediatric PAH but may be useful when TR tracing is unreliable. Figure 1b shows an increased peak velocity of the PR jet and an increased end-diastolic velocity, showing an increased mPAP and dPAP. The mPAP is calculated as the PR gradient, with a markedly increased value of 48 mmHg compared to normal values (<25 mmHg). The pulmonary capillary wedge pressure (PCWP) can be estimated via the Nagueh formula (E/e′) where e′ is the average tissue Doppler imaging velocity of E′ lateral and E′ septum. Thus, the mean transpulmonary gradient can be estimated by determining the difference between mPAP estimated by PR jet (i.e., early-diastolic maximum velocity + mRAP) and the PCWP estimated by the Nagueh formula (E/e′).29
A limitation of mPAP and dPAP estimations is that TR and PR velocities must be sampled from multiple views to assure the best envelope and maximal velocity. An overestimation of the RAP and the use of inadequate Doppler signals were also identified as frequent pitfalls in TTE that lead to incorrect assumption of PAP values.30
PA acceleration time
PA acceleration time (PAAT) is the interval in milliseconds from the onset of ejection to the peak flow velocity and can be used for assessment of PVR.31 The forward flow velocity profile, obtained in the PA just distal to the pulmonary valve, is used to obtain the PAAT.31 In adults at risk for PAH, a PAAT of less than 100 ms indicates a high probability of increased PAP.32 A PAAT > 100 ms suggests that there is no PAH, whereas a PAAT < 100 ms would increase the likelihood that PAH is present. The normal pulsed-wave (PW) Doppler profile in the RVOT is smooth, parabolic, and without “notching” of the Doppler envelope. A notch is associated with increased PVR among a cohort of adults with PAH.33 In children, a PAAT > 120 ms was described to distinguish between PAH patients and healthy controls.34 Figure 2 shows a short PAAT in a 9-year-old patient with PAH. For correct interpretation of PAAT, correct placement of the cursor in the middle of the PA and accurate alignment along the PA long axis are essential.
Even when a TR signal is lacking, PAAT measurement is possible in 99% of patients, thereby providing an alternative estimation of PVR in adults.31 The PAAT can also provide useful information that aids in the accuracy of PH diagnosis. Limitations of this method are that, in patients with left-to-right shunts, the PAAT should be interpreted carefully35 and that absolute PAAT values are very much heart rate dependent; the ratio of PAAT to PA ejection time has therefore been proposed to correct for the shortening of ejection with higher heart rates.
Presence of a pericardial effusion
The presence of a pericardial effusion (PE) is prognostic and indicates poorer survival in adult PAH patients.36 The findings show that even a small amount of PE in an adult PAH patient portends poor prognosis.36 PEs in adult PAH patients appear to relate to RV failure and evaluation of right-sided filling pressures, along with right atrial (RA) hypertension and increased pressure in the coronary sinus.37 The appearance of a new moderate or larger PE has been shown to be associated with increased mortality in adults, whereas this did not hold true when only a small PE developed.38 A limitation on the relevance of a PE is that there currently are not sufficient data on the prognostic significance of a PE in pediatric PH.
TRV/RVOT velocity time integral (VTI) ratio
There is a trend toward widespread noninvasive assessment of PVR in clinical practice. As the PVR increases, earlier and enhanced reflections of the pressure-wave profile of the RVOT appear, along with substantial changes in the RVOT VTI.39-42 The RVOT VTI can be obtained by placing a PW Doppler sample volume in the proximal RVOT just within the pulmonary valve when imaged from the PSAX view. Vlahos et al.43 also reported an excellent correlation between TRV/RVOT VTI and PVR in adult patients with moderate to severe pulmonary vascular disease. An increase in PVR is followed by a decrease in the RVOT VTI.43 In that study population about half of the patients were pediatric.43 After this relationship, when sPAP increases in PAH patients, TRV will increase and RVOT VTI is expected to decrease. The TRV/RVOT VTI ratio has recently been shown to correlate well with PVR measured at catheterization in pediatric PH patients.44 Pande et al.44 showed that, in this pediatric cohort (mean age: 9.7 years), the TRV/RVOT VTI ratio value of 0.14 provided a sensitivity of 96% and a specificity of 93% for a PVR of 6 Wood units. Normative pediatric RVOT VTI values were recently published.45 These normative RVOT VTI values will help to overcome the problem of the currently limited use of the TRV/RVOT VTI ratio in children.
A limitation of RVOT imaging by TTE is the result of a lack of fixed reference points to ensure optimization of the RVOT. Using the RVOT VTI as an estimate of pulmonary flow has the additional limitation that it assumes a circular geometry of the RVOT; this might be the case in healthy children, but it is not in pediatric or adult patients with PH.
Global and regional functional assessment of the RV
RV longitudinal systolic function
Several indices for the assessment of longitudinal RV function are available, including the tricuspid annular plane systolic excursion (TAPSE).46 TAPSE reflects longitudinal excursion of the tricuspid annulus toward the apex and is measured by M-mode from the 4-chamber view.47 TAPSE changes with growth and increases from preterm infants to healthy adolescents.47,48 Reference values of TAPSE measurements in adults and across the pediatric age range are available.49,50 Recently published guidelines for the performance of a pediatric echocardiogram recommend TAPSE for the investigation of longitudinal RV function.23 TAPSE is a reproducible index of RV systolic function in adult PH patients, and a reduced TAPSE has a high specificity for RV dysfunction.51 A TAPSE of < 2 cm suggests that the RVEF is <40% in adults.52 For every 1-mm decrease in TAPSE, the risk of death increases by 17% for adult PAH patients.51 A significant amount of PH in childhood is CHD associated,53 be it likely causally linked (large systemic left-to-right shunt) or out of proportion (e.g., severe PH in the setting of a small secundum atrial septal defect or left heart lesions). With sustained PH over years in children and young adults, TAPSE values decrease, progressively diverging from age-matched control values.54 Thus, a decrease in TAPSE values may indicate a decline in RV systolic function. Figure 3 shows a significantly decreased TAPSE in a 12-year-old PH patient, with z-scores far below age-predicted values. A negative correlation was found between MRI-determined indexed RV end-diastolic volume (EDV) and TAPSE in patients with PH-CHD. The patients in this study suffered from PH-CHD after heart surgery in childhood and therefore show a difference from iPH patients.54 In a prospective study of 66 treatment-naive children with PH, the value of various clinical and echocardiographic measures in predicting transplant-free survival was examined and showed that treatment-induced changes in TAPSE were associated with improved survival.55 TAPSE significantly improves after initiation or addition of PH therapy in pediatric PH patients.56 A limitation of this method is that, although TAPSE appears to be a good indicator of global RV function, it does not take into account segmental RV dysfunction and contractility, such as decreased apical function. TAPSE also has a wide range of normal values.50 Therefore, additional parameters should be combined with TAPSE for a more comprehensive and accurate assessment of RV systolic function.
RV fractional area change
The RV fractional area change (FAC), representing the ratio of systolic area to diastolic area, is still a commonly used index of RV contraction. RV FAC is likely less reproducible than TAPSE but accounts for apical as well as basal function and for radial as well as longitudinal function, and it incorporates heart size.51 Incomplete visualization of the RV cavity, which is more common in RV enlargement, has been shown to lead to a higher inter- and intraobserver variability.51 In a recent pediatric PH study, FAC was correlated with indexed RV stroke work and TAPSE.57 We believe that FAC should be combined with other parameters for the assessment of RV function in children with PAH. A limitation of this method is that, like any ejection-phase measurement, the RV FAC is dependent on loading conditions. Another limitation is the usually suboptimal endocardial tracing of the anterior RV wall.51
Deformation imaging (RV strain and strain rate)
Regional wall motion abnormalities are relatively common in PH patients. Strain and strain rate seem to be useful in detecting such abnormalities and can be calculated noninvasively in both the LV and the RV, providing information on regional myocardial deformation and hence dysfunction in a variety of clinical settings. Myocardial velocities and displacement are influenced by global cardiac translational motion and by motion in adjacent myocardial segments. This limitation can be overcome by myocardial strain imaging. Strain is expressed as the percentage change in length from the original length. Strain rate is the rate of deformation (per second). Changes in strain rate have been suggested to better reflect changes in contractility as they occur in early systole and are perhaps less influenced by loading conditions.58 Strain rate imaging provides a tool to quantify regional RV dysfunction in adult patients with PAH and reveals a characteristic regional pattern of abnormal RV free-wall function (Fig. 4).59 It has been shown in adults that the more severe the PH, the more impaired the end-systolic longitudinal strain in the RV free wall.60 While RV strain reflects myocardial performance, it is influenced by increased afterload and will decrease with increasing RV afterload.61 RV global longitudinal peak systolic strain and strain rate were significantly impaired in adults with PH, compared to controls,62 with RV systolic strain most altered in patients with severe PH, when compared with patients with mild PH.62 Significant correlations between RV strain and strain rate and mPAP were found in adult PAH patients.63 The important value of serial measurement of RV systolic strain in the prediction of long-term prognosis was also shown in patients with PH.64 An individual improvement of >5% in RV strain at follow-up correlated with better pulmonary hemodynamics, improved clinical status, and less clinical evidence of RV failure. An RV strain improvement of >5% may also predict greater long-term survival in PH patients.64 This was also suggested in a small study in pediatric PH patients, where strain may be an earlier predictor of RV dysfunction than conventional measures, as well as revealing regional differences.65
Normative deformation values for healthy children are available.66 Deformation imaging has also been performed in healthy and asphyxiated neonates.67-69 Reduced longitudinal RV deformation has been shown in patients with congenitally corrected transposition of the great arteries suffering from increased RV afterload.70 Dragulescu and Mertens71showed that speckle-tracking techniques can be used in children to quantify longitudinal and circumferential strain.
The limitations of strain and strain rate measurements are the relatively low temporal solution of 2D speckle tracking in the presence of high heart rates and the postprocessing time. Strain rate, in particular, results in inherently noisy signals and therefore low reproducibility. Consequently, at this time strain rate is a useful research tool (Fig. 5) but is not routinely used in clinical practice. Improving postprocessing times will probably result in a more routine application of strain rate in children.72 Further study is needed to determine whether RV strain will provide a more sensitive tool to determine early or deteriorating RV dysfunction in pediatric PH.
Systolic-to-diastolic duration ratio
The Doppler-derived ratio of systolic duration to diastolic duration (S/D) was initially described in 2006.73 Heart rate is a major determinant of systolic and diastolic duration, and at rest the former constitutes about 40% of the cardiac cycle duration in healthy children.74,75 The S/D ratio is not dependent on heart size, which increases its worth and applicability in children. In children with PH, a significantly impaired S/D ratio was proposed as an indicator of RV dysfunction as well as adverse ventricular-ventricular interactions.76 Children with significant PH have a marked decrease in diastolic duration and an increased S/D ratio, compared to control subjects, that progressively worsened with increasing heart rate.76 An increased S/D ratio > 1.4 inversely correlated with survival in pediatric PH.76 Figure 6 shows an increased S/D ratio in a 15-year-old adolescent with PH-CHD.
A limitation of the S/D ratio is that it requires the presence of clearly defined onset and end of TR on Doppler tracings. The S/D ratio is also influenced by heart rate and loading conditions. Although contraction is prolonged in PH, it is important to remember that ejection time is shortened in severe PH. Therefore, diastolic duration may be even shorter than systolic ejection time.77
Tissue Doppler velocities
Tissue Doppler velocities can be used to assess regional myocardial function. In the normal RV, there is predominantly longitudinal orientation of the RV myofibers, especially in the deeper layer, and consequently normal RV function is predominantly longitudinal. Longitudinal tissue Doppler imaging (TDI) velocities are therefore pertinent to assess systolic and diastolic RV function. Good correlations between systolic velocities and RVEF were found in an adult population that included patients with CHD.78 Normal pediatric TDI data have been published.79-81 Tissue velocities vary with age and heart rate and correlate with cardiac growth;82 therefore, tissue velocities are not independent of geometry—which has important implications in children with CHD, who have variable RV size, mass, and geometry. In healthy neonates born at or near term, the longitudinal systolic tricuspid annular peak velocity (S′) was only 1.2 times the mitral annular velocity.83 This differs from adults, in whom tricuspid annular velocity is much higher than mitral annular velocities. This difference may be the result of the increased afterload faced by the neonatal RV, compared to the adult RV. In adults, TDI measurements have been shown to have a sensitivity of only 33% and a specificity of 100% to identify patients with precapillary PAH and a negative predictive value of 85% to exclude precapillary PAH.84 The S′ has been demonstrated to be significantly reduced in adult PAH patients with reduced RV function.85 In children with PH-CHD, the tricuspid annular S′ has been shown to be significantly impaired.80 RV TDI parameters such as S′ correlate well with invasive pulmonary hemodynamics in pediatric PH-CHD patients and may therefore be useful for follow-up of these patients.86 TDI velocities may also be useful markers of midterm outcomes in children with iPH.87 Pediatric PH patients had lower S′ and early-diastolic velocities (E) at the lateral tricuspid, septal, and lateral mitral walls, compared to controls.88 These systolic and diastolic abnormalities may worsen with increasing age.89 Figure 7 shows decreased S′ values in a 16-year-old PH patient. TDI is applicable independent of chamber morphology and is not based on geometrical assumptions. The S′ is suggested to be useful for serial assessment of RV systolic function in pediatric patients.90 The limitations of TDI are predominantly related to dependence on loading conditions, assessment of myocardial motion in a single dimension, dependency on heart size, and the dependency on interrogation angle.
Myocardial performance index (Tei index)
The myocardial performance (Tei) index evaluates global ventricular function by measuring the ratio of isovolumic contraction and relaxation time intervals to ventricular ejection.91 The longer the isovolumic phases, the higher the Tei index and the worse the RV performance. The Tei index has been reported to be important in the prediction of the outcome in children with heart failure and after repair of tetralogy of Fallot.92,93 The RV Tei index has also been determined with TDI, allowing simultaneous measurement of systolic and diastolic velocities. The RV Tei index correlates well with right heart catheterization (RHC) parameters, including sPAP and mPAP, showing that it is influenced by loading conditions.94 Children with PH have an increased Tei index compared to normal controls, more prominent in older children.89 In children with PH, an increased Tei index is suggested to predict an RV dysfunction.95 Figure 8 depicts the calculation of the Tei index in an 11-year-old patient with PH.
Advantages of the Tei index are that it is a combined ventricular-vascular index and can be measured independently of ventricular geometry. Its limitations include combination of systolic and diastolic time intervals, which does not allow distinction between systolic and diastolic dysfunction. With increased afterload, both isovolumic contraction and relaxation durations increase. Therefore, this index reflects increased RV afterload and not only RV dysfunction.
Volumetric assessment of the RV
RV/LV diameter ratio
The RV/LV ratio was derived to combine a measure of RV size with septal shift secondary to elevated RV pressure. The RV/LV ratio, measured in the PSAX view at the level of the papillary muscles at end-systole, is an index that has been shown to correlate well with invasive hemodynamic measures in children with PH.96 The RV/LV ratio reflects the compression of the LV by the hypertensive RV and has been shown to be significantly higher in children with PH than in controls, and an RV/LV ratio > 1 was associated with increased risk for adverse events in pediatric PH.96
The RV/LV end-systolic diameter (ESD) ratio can be easily obtained in the clinical setting and used for serial follow-up. Correct technique is important, as incorrect angulation can lead to under- or overestimation of ventricular diameters. This ratio is limited in patients with RV volume loading due to left-to-right shunt lesions or significant PR where RV size is increased only from volume loading.
LV eccentricity index
In the pressure-loaded RV, septal flattening occurs in end-systole, resulting in an increased end-systolic LV eccentricity index (EI).97 The LV EI is the ratio of the LV dimension in the minor axis parallel to the septum divided by the LV dimension in the minor axis perpendicular to the septum. Eccentricity index is determined in end-systole and end-diastole. An increased diastolic LV EI > 1, together with diastolic septal flattening, has been shown to predict adverse outcomes in adult idiopathic PAH (IPAH) patients, and this index is likely to be useful for stratification of prognosis in pediatric PH as well.98,99 Figure 9 shows a significantly increased RV/LV ratio in a 13-year-old patient with PH-CHD. Limitations of this index are that slightly off-axis images may result in an artificially flattened septum, which may falsely increase the index, and that an inaccurate identification of the end-systole may influence the index.
RV and LV diastolic function
PH is commonly associated with diastolic RV dysfunction that precedes the impairment of systolic RV function. In the apical 4-chamber view, a PW Doppler beam should be aligned as parallel as possible to RV inflow. The sample volume should be placed at the tip of the tricuspid leaflets.100 The evaluation of RV diastolic function includes tricuspid inflow velocities (E, A, E/A), TDI of the tricuspid annulus (E′, A′, and E′/A′), and deceleration time. The tricuspid E/E′ ratio, RA area, and diastolic strain rate have promise in the evaluation of RV diastolic function. In adult studies with chronic heart failure and PH, the presence of RV diastolic dysfunction is associated with worse functional class and is an independent predictor of mortality.101 In children with bronchopulmonary dysplasia, increasing tricuspid E/E′ correlates with clinical severity of the disease.102 In children with iPH, tricuspid valve E′ correlates with mPAP and RV end-diastolic pressure.87 In a recent study, diastolic parameters of RV in children with PH correlated with invasive measures of cardiac catheterization.103
Tricuspid inflow measures can be achieved with high reproducibility.104 The presence of moderate to severe TR can confound measurements of the tricuspid inflow velocities and are excluded from most studies. In PH patients with advanced disease and evident RV-mediated impairment of LV filling, the late-diastolic LV filling pattern through the mitral valve will reverse, leading to E < A, and a short E deceleration time has been observed in adults.105 The pulmonary venous Doppler flow can be abnormal in patients with LV diastolic dysfunction. In patients with PH from left-sided heart disease, the evaluation of mitral valve and pulmonary veins remains important in determining the cause of PH. Evaluation of LV systolic function can be measured by EF from biplane Simpson’s formula106 and the area-length method (Bullet) measuring LV end-diastolic diameter (EDD) and LVESD in the 4-chamber view and FAC in the PSAX view (LVEF = (LVEDV − LVESD)∶LVEDD, where LV volumes are calculated monoplane as follows: LV volume = 5/6 × LV area SAX × LV length).107
RV and RA enlargement
In adults, a basal RV diameter of >42 mm and a midcavity diameter of >35 mm have been shown to indicate RV dilation. Similarly, an end-diastolic length of >86 mm indicates RV enlargement.18 For the area of the RV, often the area divided by body surface area (the “indexed” area) is used. The ASE has published recommendations for quantification methods during the performance of a pediatric echocardiogram, with the RV internal-dimension parameters described as useful but with normative data for a comparison to dilated RVs still not available.23 Recently, normative data of the pediatric RV internal dimensions have been published,108,109 with sufficient TTE data of enlarged RV dimensions in pediatric PH currently missing. RV and RA enlargement, plus interatrial septal bowing from right to left (as shown in Fig. 10 in a 16-year-old adolescent with PH), indicates poor RV compliance, increased mean RAP, or both in adults.110
The measurement of RA dimensions, including RA diameter and area, in an apical 4-chamber view is a simple variable. An RA area > 20 cm2 has been shown to be abnormal, and an RA area > 27 cm2 showed a higher rate of death in adults with IPAH.110,111 In adult patients with chronic PAH, the RA size significantly increases and parallels signs of activation of the Frank-Starling mechanism in both right chambers. The RA size has been shown to be positively related to larger RV dimensions.112 The IVC can be dilated in patients with PH because of rising RAP. It is measured in the subcostal longitudinal view with the IVC entering the RA. RAP can be estimated by IVC diameter and the presence of inspiratory collapse in adults.113,114 An IVC diameter of <2 cm that collapses by >50% with a sniff suggests a normal RAP of 3 mmHg (range: 0–5 mmHg) in adults. An IVC diameter of >2 cm that collapses by <50% with a sniff suggests a high RAP of 15 mmHg (range: 10–20 mmHg).113,115 In children, the IVC varies with age of the patient. Elevated RAP in children can be assessed by the percentage of collapse of the IVC during inspiration rather than by an absolute number. For the pediatric PH cohort, limited data for a comparison to a dilated RA are available, in contrast to RV size.109 One of the major limitations of the reliability of RA and RV size determination is that only limited TTE data on RA and RV size enlargement in pediatric PH are available.
3D echocardiography
The most common 3D method of assessing RV volume in PH patients uses semiautomated border detection and a model of the RV that is used in semiautomated RV volume reconstruction.116,117 Disk summation and apical rotational methods for RV volume and EF calculation have been shown to correlate well with MRI volume and EF in children118 and adults.119 RVEDV calculations of 3D data sets are available, with good correlations with other techniques, such as the MRI.120,121 The lower reference limit for RVEF is 44%, from the disk summation method in adult patients. In a recent study by Kong et al.,122 regional and global RV systolic dysfunction in adult PH patients measured by 3D echocardiography were inversely related to the pulmonary arterial systolic pressure and PVR. Normal values with this technique for RV size and function in adults have been published.123 Three-dimensional echocardiography outperformed 2D echocardiography in the assessment of RV volumes and compared favorably with cardiac MRI.124 In adults with PAH, good correlation was found in the calculation of RVEF and RVEDV determined by either 3D echocardiography or MRI measurements.125 It was recently shown that adult patients with some forms of PH had more dilated, hypertrophied, and poorly functioning RVs than adults with other forms.126 The use of 3D echocardiography has been validated for the measurement of RV volumes and EF, which correlated well with those variables determined by MRI imaging in a pediatric population.127 Validation of 3D echocardiographic assessment in children with complex CHD, including a small LV, has been performed,128 while sufficient data in children with PH are scant. A limitation of this method is that 3D echocardiography is dependent on adequate acoustic windows, which had been appropriate in only about 50% of all patients,129 because of inadequate image quality. Furthermore, an underestimation of the RV volume, when compared to MRI measurements, was reported from different groups that found the underestimation of RV volumes by 3D echocardiography mainly occurring in severely dilated RVs.119,130
Summary
In this review, we summarize the use of basic standard and more extended TTE variables in pediatric PH patients. TTE findings of suspected PH alone are not sufficient to establish the diagnosis of a pediatric PH and also not sufficient to initiate a specific therapy.1,131 While important and mandatory for the initial confirmation of the diagnosis, a comprehensive RHC appears to be associated with a higher rate of complications in children than in adults and therefore requires specific expertise.1,132 The use of TTE supports a goal-oriented “treat to target” therapy in adults and pediatric patients with PH.133 Longitudinal investigations are of paramount importance in determining the effects of PH-specific therapies on growth and puberty in pediatric patients.134 It is essential that TTE protocols for PH patients include assessment of RV hemodynamics, global and regional RV function, and RV volumetry. Although data on pediatric PH are still scant, we created a pediatric imaging protocol for use of TTE in the initial diagnosis, follow-up, and treatment of children with PH (Table 1) as our “best practices” for a TTE evaluation of children with various types of PH. The main focus of this review was on systolic RV function and size adaptation to increased RV afterload, but diastolic function changes must also be taken into consideration. Increased RA and RV surface areas, an altered EI, estimates of RAP from diastolic function indices, the RV Tei index, and several other variables are surrogate markers of diastolic RV function provided by TTE.135-137 Echocardiographic 3D assessment of ventricular volumes and calculated RVEF and LVEF has made significant progress over the past decade, although it does not reach the accuracy of the gold-standard cardiac MRI.
More important than just measuring FAC, TAPSE, TDI, or other variables to assess RV function is properly performed investigation by the sonographer. Cardiac sonographers should become familiar with both traditional and newer techniques for more detailed assessments of ventricular performance in children with PH and/or ventricular dysfunction.10 Clinicians must develop an understanding of RV size and RV function measurements so that these can be integrated into clinical practice.
Regular and consistent usage of a TTE protocol may increase the identification of children with PH, leading to earlier comprehensive diagnosis and treatment. In concert with lab tests and exercise testing, these TTE variables are useful for the diagnostic workup and assessment of staging the disease in PH patients. A detailed TTE evaluation might reduce the cost of intensive and logistically demanding follow-up investigations such as cardiac MRI or cardiac catheterization, especially in the pediatric age group, in the future.
Source of Support: GH receives grant support from the German Research Foundation (DFG; HA 4348/2–1), Fördergemeinschaft deutsche Kinderherzzentren (W-H-001–2014), and Stiftung Kinderherz (2511–6–13–011).
Conflict of Interest: None declared.
References
- 1.Beghetti M, Berger RM, Schulze-Neick I, Day RW, Pulido T, Feinstein J, Barst RJ, Humpl T. Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice. Eur Respir J 2013;42(3):689–700. [DOI] [PubMed]
- 2.McGoon MD, Miller DP. REVEAL: a contemporary US pulmonary arterial hypertension registry. Eur Respir Rev 2012;21(123):8–18. doi:10.1183/09059180.00008211. [DOI] [PMC free article] [PubMed]
- 3.Van Loon RL, Roofthooft MTR, Hillege HL, ten Harkel ADJ, van Osch-Gevers M, Delhaas T, Kapusta L, et al. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005. Circulation 2011;124(16):1755–1764. [DOI] [PubMed]
- 4.Berger RMF, Beghetti M, Humpl T, Raskob GE, Ivy DD, Jing ZC, Bonnet D, Schulze-Neick I, Barst RJ. Clinical features of paediatric pulmonary hypertension: a registry study. Lancet 2012;379(9815):537–546. [DOI] [PMC free article] [PubMed]
- 5.Ploegstra MJ, Roofthooft MT, Douwes JM, Bartelds B, Elzenga NJ, van de Weerd D, Hillege HL, Berger RM. Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome. Circ Cardiovasc Imaging 2015;8:e000878. doi:10.1161/CIRCIMAGING.113.000878. [DOI] [PubMed]
- 6.Simonneau G, Gatzoulis M, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013;62(25 suppl.):D34–D41. [DOI] [PubMed]
- 7.Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 2010;137(2):376–387. [DOI] [PubMed]
- 8.Schulze-Neick I, Beghetti M. Issues related to the management and therapy of paediatric pulmonary hypertension. Eur Respir Rev 2010;19(118):331–339. doi:10.1183/09059180.00008510. [DOI] [PMC free article] [PubMed]
- 9.Vonk Noordegraaf A, Haddad F, Bogaard HJ, Hassoun PM. Noninvasive imaging in the assessment of the cardiopulmonary vascular unit. Circulation 2015;131(10):899–913. [DOI] [PubMed]
- 10.D’Alto M, Romeo E, Argiento P, Di Salvo G, Badagliacca R, Cirillo AP, Kaemmerer H, Bossone E, Naeije R. Pulmonary arterial hypertension: the key role of echocardiography. Echocardiography 2015;32(suppl. S1):S23–S37. [DOI] [PubMed]
- 11.D’Alto M, Romeo E, Argiento P, D’Andrea A, Vanderpool R, Correra A, Bossone E, et al. Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension. Int J Cardiol 2013;168(4):4058–4062. [DOI] [PubMed]
- 12.Benavidez OJ, Gauvreau K, Jenkins KJ, Geva T. Diagnostic errors in pediatric echocardiography: development of taxonomy and identification of risk factors. Circulation 2008;117(23):2995–3001. [DOI] [PMC free article] [PubMed]
- 13.Koestenberger M, Friedberg MK, Ravekes W, Nestaas E, Hansmann G. Non-invasive imaging for congenital heart disease: recent innovations in transthoracic echocardiography. J Clin Exp Cardiol 2012;S8:002. doi:10.4172/2155-9880.S8-002. [DOI] [PMC free article] [PubMed]
- 14.Moledina S, Pandya B, Bartsota M, Mortensen KH, McMillan M, Quyam S, Taylor AM, Haworth SG, Schulze-Neick I, Muthurangu V. Prognostic significance of cardiac magnetic resonance imaging in children with pulmonary hypertension. Circ Cardiovasc Imaging 2013;6(3):407–414. [DOI] [PubMed]
- 15.Sheehan F, Redington A. The right ventricle: anatomy, physiology and clinical imaging. Heart 2008;94(11):1510–1515. [DOI] [PubMed]
- 16.Bossone E, D’Andrea A, D’Alto M, Citro R, Argiento P, Ferrara F, Cittadini A, Rubenfire M, Naeije R. Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. J Am Soc Echocardiogr 2013;26(1):1–14. [DOI] [PubMed]
- 17.Friedberg MK, Redington AN. Right versus left ventricular failure: differences, similarities, and interactions. Circulation 2014;129(9):1033–1044. [DOI] [PubMed]
- 18.Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography: endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23(7):685–713. [DOI] [PubMed]
- 19.Lancellotti P, Budts W, De Wolf D, Voigt JU, Pasquet A, De Sutter J, Friart A, Huez S, Paelinck B, Vachiéry JL. Practical recommendations on the use of echocardiography to assess pulmonary arterial hypertension—a Belgian expert consensus endorsed by the Working Group on Non-Invasive Cardiac Imaging. Acta Cardiol 2013;68(1):59–69. [DOI] [PubMed]
- 20.Badano LP, Ginghina C, Easaw J, Muraru D, Grillo MT, Lancellotti P, Pinamonti B, et al. Right ventricle in pulmonary arterial hypertension: haemodynamics, structural changes, imaging, and proposal of a study protocol aimed to assess remodelling and treatment effects. Eur J Echocardiogr 2010;11(1):27–37. [DOI] [PubMed]
- 21.Baruteau AE, Belli E, Boudjemline Y, Laux D, Lévy M, Simonneau G, Carotti A, Humbert M, Bonnet D. Palliative Potts shunt for the treatment of children with drug-refractory pulmonary arterial hypertension: updated data from the first 24 patients. Eur J Cardiothorac Surg 2015;47(3):e105–e110. [DOI] [PubMed]
- 22.Latus H, Apitz C, Moysich A, Kerst G, Jux C, Bauer J, Schranz D. Creation of a functional Potts shunt by stenting the persistent arterial duct in newborns and infants with suprasystemic pulmonary hypertension of various etiologies. J Heart Lung Transplant 2014;33(5):542–546. [DOI] [PubMed]
- 23.Lopez L, Colan SD, Frommelt PC, Ensing GJ, Kendall K, Younoszai AK, Lai WW, Geva T. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr 2010;23(5):465–495. [DOI] [PubMed]
- 24.Jone PN, Ivy DD. Echocardiography in pediatric pulmonary hypertension. Front Pediatr 2014;2:124. doi:10.3389/fped.2014.00124. [DOI] [PMC free article] [PubMed]
- 25.Espinola-Zavaleta N, Soto ME, Romero-Gonzalez A, Gómez-Puente LdC, Muñoz-Castellanos L, Gopal AS, Keirns C, Lupi-Herrera E. Prevalence of congenital heart disease and pulmonary hypertension in Down’s syndrome: an echocardiographic study. J Cardiovasc Ultrasound 2015;23(2):72–77. [DOI] [PMC free article] [PubMed]
- 26.Pyxaras SA, Pinamonti B, Barbati G, Santangelo S, Valentincic M, Cettolo F, Secoli G, et al. Echocardiographic evaluation of systolic and mean pulmonary artery pressure in the follow-up of patients with pulmonary hypertension. Eur J Echocardiogr 2011;12(9):696–701. [DOI] [PubMed]
- 27.Masuyama T, Kodama K, Kitabatake A, Sato H, Nanto S, Inoue M. Continuous-wave Doppler echocardiographic detection of pulmonary regurgitation and its application to noninvasive estimation of pulmonary artery pressure. Circulation 1986;74(3):484–492. [DOI] [PubMed]
- 28.del Cerro MJ, Abman S, Diaz G, Freudenthal AH, Freudenthal F, Harikrishnan S, Haworth SG, et al. A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: report from the PVRI Pediatric Taskforce, Panama 2011. Pulm Circ 2011;1(2):286–298. [DOI] [PMC free article] [PubMed]
- 29.Nagueh, SF, Mikati I, Kopelen HA, Middleton KJ, Quiñones MA, Zoghbi WA. Doppler estimation of left ventricular filling pressure in sinus tachycardia: a new application of tissue Doppler imaging. Circulation 1998;98(16):1644–1650. [DOI] [PubMed]
- 30.Fisher MR, Forfia PR, Chamera E, Housten-Harris T, Champion HC, Girgis RE, Corretti MC, Hassoun PM. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009;179(7):615–621. [DOI] [PMC free article] [PubMed]
- 31.Yared K, Noseworthy P, Weyman AE, McCabe E, Picard MH, Baggish AL. Pulmonary artery acceleration time provides an accurate estimate of systolic pulmonary arterial pressure during transthoracic echocardiography. J Am Soc Echocardiogr 2011;24(6):687–692. [DOI] [PubMed]
- 32.Granstam SO, Björklund E, Wikström G, Roos MW. Use of echocardiographic pulmonary acceleration time and estimated vascular resistance for the evaluation of possible pulmonary hypertension. Cardiovasc Ultrasound 2013;11:7. doi:10.1186/1476-7120-11-7. [DOI] [PMC free article] [PubMed]
- 33.Arkles JS, Opotowsky AR, Ojeda J, Rogers F, Liu T, Prassana V, Marzec L, Palevsky HI, Ferrari VA, Forfia PR. Shape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in pulmonary hypertension. Am J Respir Crit Care Med 2011;183(2):268–276. [DOI] [PubMed]
- 34.Cevik A, Kula S, Olgunturk R, Tunaoglu FS, Oguz AD, Saylan B, Cilsal E, Sanli C. Assessment of pulmonary arterial hypertension and vascular resistance by measurements of the pulmonary arterial flow velocity curve in the absence of a measurable tricuspid regurgitant velocity in childhood congenital heart disease. Pediatr Cardiol 2013;34:646–655. [DOI] [PubMed]
- 35.Matsuda M, Sekiguchi T, Sugishita Y, Kuwako K, Iida K, Ito I. Reliability of non-invasive estimates of pulmonary hypertension by pulsed Doppler echocardiography. Br Heart J 1986;56(2):158–164. [DOI] [PMC free article] [PubMed]
- 36.Fenstad ER, Le RJ, Sinak L, Maradit-Kremers H, Ammash NM, Ayalew A, Villarraga H, et al. Pericardial effusions in pulmonary arterial hypertension: characteristics, prognosis, and role of drainage. Chest 2013;144(5):1530–1538. [DOI] [PubMed]
- 37.Natanzon A, Kronzon I. Pericardial and pleural effusions in congestive heart failure—anatomical, pathophysiologic, and clinical considerations. Am J Med Sci 2009;338(3):211–216. [DOI] [PubMed]
- 38.Shimony A, Fox B, Langleben D, Rudski L. Incidence and significance of pericardial effusion in patients with pulmonary arterial hypertension. Can J Cardiol 2013;29(6):678–682. [DOI] [PubMed]
- 39.Kouzu H, Nakatani S, Kyotani S, Kanzaki H, Nakanishi N, Kitakaze M. Noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension. Am J Cardiol 2009;103(6):872–876. [DOI] [PubMed]
- 40.Nakahata Y, Hiraishi S, Oowada N, Ando H, Kimura S, Furukawa S, Ogata S, Ishii M. Quantitative assessment of pulmonary vascular resistance and reactivity in children with pulmonary hypertension due to congenital heart disease using a noninvasive method: new Doppler-derived indexes. Pediatr Cardiol 2009;30(3):232–239. [DOI] [PubMed]
- 41.Tonelli AR, Conci D, Tamarappoo BK, Newman J, Dweik RA. Prognostic value of echocardiographic changes in patients with pulmonary arterial hypertension receiving parenteral prostacyclin therapy. J Am Soc Echocardiogr 2014;27(4):733–741. [DOI] [PMC free article] [PubMed]
- 42.Abbas AE, Franey LM, Marwick T, Maeder MT, Kaye DM, Vlahos AP, Serra W, Al-Azizi K, Schiller NB, Lester SJ. Noninvasive assessment of pulmonary vascular resistance by Doppler echocardiography. J Am Soc Echocardiogr 2013;26(10):1170–1177. [DOI] [PubMed]
- 43.Vlahos AP, Feinstein JA, Schiller NB, Silverman NH. Extension of Doppler-derived echocardiographic measures of pulmonary vascular resistance to patients with moderate or severe pulmonary vascular disease. J Am Soc Echocardiogr 2008;21(6):711–714. [DOI] [PubMed]
- 44.Pande A, Sarkar A, Ahmed I, Naveen Chandra G, Patil SK, Kundu CK, Arora R, Samanta A. Non-invasive estimation of pulmonary vascular resistance in patients of pulmonary hypertension in congenital heart disease with unobstructed pulmonary flow. Ann Pediatr Cardiol 2014;7(2):92–97. [DOI] [PMC free article] [PubMed]
- 45.Koestenberger M, Nagel B, Ravekes W, Avian A, Burmas A, Grangl G, Cvirn G, Gamillscheg A. Right ventricular outflow tract velocity time integral determination in 570 healthy children and in 52 pediatric atrial septal defect patients. Pediatr Cardiol 2015;36(6):1129–1134. [DOI] [PubMed]
- 46.Miller D, Farah MG, Liner A, Fox K, Schluchter M, Hoit BD. The relation between quantitative right ventricular ejection fraction and indices of tricuspid annular motion and myocardial performance. J Am Soc Echocardiogr 2004;17(5):443–447. [DOI] [PubMed]
- 47.Koestenberger M, Nagel B, Ravekes W, Everett AD, Stueger H, Heinzl B, Sorantin E, Cvirn G, Fritsch P, Gamillscheg A. Systolic right ventricular function in pediatric and adolescent patients with tetralogy of Fallot: echocardiography versus magnetic resonance imaging. J Am Soc Echocardiogr 2011;24(1):45–52. [DOI] [PubMed]
- 48.Koestenberger M, Nagel B, Ravekes W, Urlesberger B, Raith W, Avian A, Halb V, Cvirn G, Fritsch P, Gamillscheg A. Systolic right ventricular function in preterm and term neonates: Reference values of the tricuspid annular plane systolic excursion (TAPSE) in 258 patients and calculation of Z-score values. Neonatology 2011;100(1):85–92. [DOI] [PubMed]
- 49.Lamia B, Teboul JL, Monnet X, Richard C, Chemla D. Relationship between the tricuspid annular plane systolic excursion and right and left ventricular function in critically ill patients. Intensive Care Med 2007;33(12):2143–2149. [DOI] [PubMed]
- 50.Koestenberger M, Ravekes W, Everett A, Stueger HP, Heinzl B, Gamillscheg A, Cvirn G, Boysen A, Fandl A, Nagel B. Right ventricular function in infants, children and adolescents: reference values of the tricuspid annular plane systolic excursion (TAPSE) in 640 healthy patients and calculation of z score values. J Am Soc Echocardiogr 2009;22(6):715–719. [DOI] [PubMed]
- 51.Forfia P, Fisher M, Mathai S, Housten-Harris T, Hemnes A, Borlaug B, Chamera E, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006;174(9):1034–1041. [DOI] [PubMed]
- 52.Lopez-Candales A, Rajagopalan N, Saxena N, Gulyasy B, Edelman K, Bazaz R. Right ventricular systolic function is not the sole determinant of tricuspid annular motion. Am J Cardiol 2006;98(7):973–977. [DOI] [PubMed]
- 53.Haworth SG, Hislop AA. Treatment and survival in children with pulmonary arterial hypertension: the UK pulmonary hypertension service for children 2001–2006. Heart 2009;95(4):312–317. [DOI] [PubMed]
- 54.Koestenberger M, Nagel B, Avian A, Ravekes W, Sorantin E, Cvirn G, Beran E, Halb V, Gamillscheg A. Systolic right ventricular function in children and young adults with pulmonary artery hypertension secondary to congenital heart disease and tetralogy of Fallot: tricuspid annular plane systolic excursion (TAPSE) and magnetic resonance imaging data. Congenital Heart Dis 2012;7(3):250–258. [DOI] [PubMed]
- 55.Ploegstra MJ, Douwes JM, Roofthooft MT, Zijlstra WM, Hillege HL, Berger RM. Identification of treatment goals in paediatric pulmonary arterial hypertension. Eur Respir J 2014;44(6):1616–1626. [DOI] [PubMed]
- 56.Bano M, Kanaan UB, Ehrlich AC, McCracken C, Morrow G, Oster ME, Sachdeva R. Improvement in tricuspid annular plane systolic excursion with pulmonary hypertension therapy in pediatric patients. Echocardiography 2015;32(8):1228–1232. [DOI] [PubMed]
- 57.Di Maria MV, Younoszai AK, Mertens L, Landeck BF II, Ivy DD, Hunter K, Friedberg MK. RV stroke work in children with pulmonary arterial hypertension: estimation based on invasive haemodynamic assessment and correlation with outcomes. Heart 2014;100(17):1342–1347. [DOI] [PubMed]
- 58.Ferferieva V, van den Bergh A, Claus P, Jasaityte R, Veulemans P, Pellens M, La Gerche A, Rademakers F, Herijgers P, D’hooge J. The relative value of strain and strain rate for defining intrinsic myocardial function. Am J Physiol Heart Circ Physiol 2012;302(1):H188–H195. [DOI] [PubMed]
- 59.Dambrauskaite, Delcroix M, Claus P, Herbots L, D’hooge J, Bijnens B, Rademakers F, Sutherland G. Regional right ventricular dysfunction in chronic pulmonary hypertension. J Am Soc Echocardiograph 2007;20(10):1172–1180. [DOI] [PubMed]
- 60.Puwanant S, Park M, Popović ZB, Tang WH, Farha S, George D, Sharp J, et al. Ventricular geometry, strain, and rotational mechanics in pulmonary hypertension. Circulation 2010;121(2):259–266. [DOI] [PMC free article] [PubMed]
- 61.Kittipovanonth M, Bellavia D, Chandrasekaran K, Villarraga HR, Abraham TP, Pellikka PA. Doppler myocardial imaging for early detection of right ventricular dysfunction in patients with pulmonary hypertension. J Am Soc Echocardiogr 2008;21(9):1035–1041. [DOI] [PubMed]
- 62.Li Y, Xie M, Wang X, Lu Q, Fu M. Right ventricular regional and global systolic function is diminished in patients with pulmonary arterial hypertension: a 2-dimensional ultrasound speckle tracking echocardiography study. Int J Cardiovasc Imaging 2013;29(3):545–551. [DOI] [PubMed]
- 63.Naderi N, Ojaghi Haghighi Z, Amin A, Naghashzadeh F, Bakhshandeh H, Taghavi S, Maleki M. Utility of right ventricular strain imaging in predicting pulmonary vascular resistance in patients with pulmonary hypertension. Congest Heart Fail 2013;19(3):116–122. [DOI] [PubMed]
- 64.Hardegree EL, Sachdev A, Villarraga H, Frantz R, McGoon M, Kushwaha S, Hsiao J, et al. Role of serial quantitative assessment of right ventricular function by strain in pulmonary arterial hypertension. Am J Cardiol 2013;111(1):143–148. [DOI] [PubMed]
- 65.Okumura K, Humpl T, Dragulescu A, Mertens L, Friedberg MK. Longitudinal assessment of right ventricular myocardial strain in relation to transplant-free survival in children with idiopathic pulmonary hypertension. J Am Soc Echocardiogr 2014;27(12):1344–1351. [DOI] [PubMed]
- 66.Weidemann F, Eyskens B, Jamal F, Mertens L, Kowalski M, D’Hooge J, Bijnens B, et al. Quantification of regional left and right ventricular radial and longitudinal function in healthy children using ultrasound-based strain rate and strain imaging. J Am Soc Echocardiogr 2002;15(1):20–28. [DOI] [PubMed]
- 67.Joshi S, Edwards JM, Wilson DG, Wong JK, Kotecha S, Fraser AG. Reproducibility of myocardial velocity and deformation imaging in term and preterm infants. Eur J Echocardiogr 2010;11(1):44–50. [DOI] [PubMed]
- 68.Nestaas E, Støylen A, Brunvand L, Fugelseth D. Tissue Doppler derived longitudinal strain and strain rate during the first 3 days of life in healthy term neonates. Pediatr Res 2009;65(3):357–362. [DOI] [PubMed]
- 69.Nestaas E, Støylen A, Brunvand L, Fugelseth D. Longitudinal strain and strain rate by tissue Doppler are more sensitive indices than fractional shortening for assessing the reduced myocardial function in asphyxiated neonates. Cardiol Young 2011;21(1):1–7. [DOI] [PubMed]
- 70.Bos JM, Hagler DJ, Silvilairat S, Cabalka A, O’Leary P, Daniels O, Miller FA, Abraham TP. Right ventricular function in asymptomatic individuals with a systemic right ventricle. J Am Soc Echocardiogr 2006;19(8):1033–1037. [DOI] [PubMed]
- 71.Dragulescu A, Mertens LL. Developments in echocardiographic techniques for the evaluation of ventricular function in children. Arch Cardiovasc Dis 2010;103(11–12):603–614. [DOI] [PubMed]
- 72.Koopman LP, Slorach C, Hui W, Manlhiot C, McCrindle BW, Friedberg MK, Jaeggi ET, Mertens L. Comparison between different speckle tracking and color tissue Doppler techniques to measure global and regional myocardial deformation in children. J Am Soc Echocardiogr 2010;23(9):919–928. [DOI] [PubMed]
- 73.Friedberg MK, Silverman NH. Cardiac ventricular diastolic and systolic duration in children with heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 2006;97(1):101–105. [DOI] [PubMed]
- 74.Friedberg MK, Silverman NH. The systolic to diastolic duration ratio in children with hypoplastic left heart syndrome: a novel Doppler index of right ventricular function. J Am Soc Echocardiogr 2007;20(6):749–755. [DOI] [PubMed]
- 75.Sarnari R, Kamal RY, Friedberg MK, Silverman NH. Doppler assessment of the ratio of the systolic to diastolic duration in normal children: relation to heart rate, age and body surface area. J Am Soc Echocardiogr 2009;22(8):928–932. [DOI] [PubMed]
- 76.Alkon J, Humpl T, Manlhiot C, McCrindle BW, Reyes J, Friedberg MK. Usefulness of the right ventricular systolic to diastolic duration ratio to predict functional capacity and survival in children with pulmonary arterial hypertension. Am J Cardiol 2010;106(3):430–436. [DOI] [PubMed]
- 77.Rain S, Handoko ML, Trip P, Gan CT, Westerhof N, Stienen GJ, Paulus WJ, et al. Right ventricular diastolic impairment in patients with pulmonary arterial hypertension. Circulation 2013;128(18):2016–2025. [DOI] [PubMed]
- 78.Wahl A, Praz F, Schwerzmann M, Bonel H, Koestner SC, Hullin R, Schmid JP, et al. Assessment of right ventricular systolic function: comparison between cardiac magnetic resonance derived ejection fraction and pulsed-wave tissue Doppler imaging of the tricuspid annulus. Int J Cardiol 2011;151(1):58–62. [DOI] [PubMed]
- 79.Swaminathan S, Ferrer PL, Wolff GS, Gómez-Marín O, Rusconi PG. Usefulness of tissue Doppler echocardiography for evaluating ventricular function in children without heart disease. Am J Cardiol 2003;91(5):570–574. [DOI] [PubMed]
- 80.Koestenberger M, Nagel B, Ravekes W, Avian A, Heinzl B, Fandl A, Rehak T, Sorantin E, Cvirn G, Gamillscheg A. Tricuspid annular peak systolic velocity (S′) in children and young adults with pulmonary artery hypertension secondary to congenital heart diseases, and in those with repaired tetralogy of Fallot: echocardiography and MRI data. J Am Soc Echocardiogr 2012;25(10):1041–1049. [DOI] [PubMed]
- 81.Koestenberger M, Nagel B, Ravekes W, Avian A, Heinzl B, Cvirn G, Fritsch P, Fandl A, Rehak T, Gamillscheg A. Reference values of tricuspid annular peak systolic velocity in healthy pediatric patients, calculation of z score, and comparison to tricuspid annular plane systolic excursion. Am J Cardiol 2012;109(1):116–121. [DOI] [PubMed]
- 82.Eidem BW, McMahon CJ, Cohen RR, Wu J, Finkelshteyn I, Kovalchin JP, Ayres NA, Bezold LI, O’Brian Smith E, Pignatelli RH. Impact of cardiac growth on Doppler tissue imaging velocities: a study in healthy children. J Am Soc Echocardiogr 2004;17(3):212–221. [DOI] [PubMed]
- 83.Mori K, Nakagawa R, Nii M, Edagawa T, Takehara Y, Inoue M, Kuroda Y. Pulsed wave Doppler tissue echocardiography assessment of the long axis function of the right and left ventricles during the early neonatal period. Heart 2004;90(2):175–180. [DOI] [PMC free article] [PubMed]
- 84.Hammerstingl C, Schueler R, Bors L, Momcilovic D, Pabst S, Nickenig G, Skowasch D. Diagnostic value of echocardiography in the diagnosis of pulmonary hypertension. PLoS ONE 2012;7(6):e38519. doi:10.1371/journal.pone.0038519. [DOI] [PMC free article] [PubMed]
- 85.McLean AS, Ting I, Huang SJ, Wesley S. The use of the right ventricular diameter and tricuspid annular tissue Doppler velocity parameter to predict the presence of pulmonary hypertension. Eur J Echocardiogr 2007;8(2):128–136. [DOI] [PubMed]
- 86.Cevik A, Kula S, Olgunturk R, Saylan B, Pektas A, Oguz D, Tunaoglu S. Doppler tissue imaging provides an estimate of pulmonary arterial pressure in children with pulmonary hypertension due to congenital intracardiac shunts. Congenit Heart Dis 2013;8(6):527–534. [DOI] [PubMed]
- 87.Takatsuki S, Nakayama T, Jone PN, Wagner BD, Naoi K, Ivy DD, Saji T. Tissue Doppler imaging predicts adverse outcome in children with idiopathic pulmonary arterial hypertension. J Pediatr 2012;161(6):1126–1131. [DOI] [PMC free article] [PubMed]
- 88.Lammers AE, Haworth SG, Riley G, Maslin K, Diller GP, Marek J. Value of tissue Doppler echocardiography in children with pulmonary hypertension. J Am Soc Echocardiogr 2012;25(5):504–510. [DOI] [PubMed]
- 89.Vorhies EE, Gajarski RJ, Yu S, Donohue JE, Fifer CG. Echocardiographic evaluation of ventricular function in children with pulmonary hypertension. Pediatr Cardiol 2014;35( 5):759–766. [DOI] [PubMed]
- 90.Pauliks L. Tissue Doppler myocardial velocity imaging in infants and children—a window into developmental changes of myocardial mechanics. Echocardiography 2013;30(4):439–446. [DOI] [PubMed]
- 91.Tei C, Ling LH, Hodge DO, Bailey KR, Oh J, Rodeheffer RJ, Tajik AJ, Seward JB. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function: a study in normals and dilated cardiomyopathy. J Cardiol 1995;26(6):357–366. [PubMed]
- 92.Petko C, Minich LL, Everitt MD, Holubkov R, Shaddy RE, Tani LY. Echocardiographic evaluation of children with systemic ventricular dysfunction treated with carvedilol. Pediatr Cardiol 2010;31(6):780–784. [DOI] [PubMed]
- 93.Yasuoka K, Harada K, Toyono M, Tamura M, Yamamoto F. Tei index determined by tissue Doppler imaging in patients with pulmonary regurgitation after repair of tetralogy of Fallot. Pediatr Cardiol 2004;25(2):131–136. [DOI] [PubMed]
- 94.Vonk MC, Sander MH, van den Hoogen FH, van Riel PL, Verheugt FW, van Dijk AP. Right ventricle Tei-index: a tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases. Eur J Echocardiogr 2007;8(5):317–321. [DOI] [PubMed]
- 95.Cevik A, Kula S, Olgunturk R, Tunaoglu FS, Oguz AD, Pektas A, Saylan B. Quantitative evaluation of right ventricle function by transthoracic echocardiography in childhood congenital heart disease patients with pulmonary hypertension. Echocardiography 2012;29(7):840–848. [DOI] [PubMed]
- 96.Jone PN, Hinzman J, Wagner BD, Ivy DD, Younoszai A. Right ventricular to left ventricular diameter ratio at end-systole in evaluating outcomes in children with pulmonary hypertension. J Am Soc Echocardiogr 2014;27(2):172–178. [DOI] [PMC free article] [PubMed]
- 97.Ryan T, Petrovic O, Dillon JC, Feigenbaum H, Conley MJ, Armstrong WF. An echocardiographic index for separation of right ventricular volume and pressure overload. J Am Coll Cardiol 1985;5(4):918–927. [DOI] [PubMed]
- 98.Ghio S, Klersy C, Magrini G, D’Armini AM, Scelsi L, Raineri C, Pasotti M, Serio A, Campana C, Viganò M. Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension. Int J Cardiol 2010;140(3):272–278. [DOI] [PubMed]
- 99.Kassem E, Humpl T, Friedberg MK. Prognostic significance of 2-dimensional, M-mode, and Doppler echo indices of right ventricular function in children with pulmonary arterial hypertension. Am Heart J 2013;165(6):1024–1031. [DOI] [PubMed]
- 100.Berman GO, Reichek N, Brownson D, Douglas PS. Effects of sample volume location, imaging view, heart rate and age on tricuspid velocimetry in normal subjects. Am J Cardiol 1990;65(15):1026–1030. [DOI] [PubMed]
- 101.Sallach JA, Tang WH, Borowski AG, Tong W, Porter T, Martin MG, Jasper SE, Shrestha K, Troughton RW, Klein AL. Right atrial volume index in chronic systolic heart failure and prognosis. JACC Cardiovasc Imaging 2009;2(5):527–534. [DOI] [PubMed]
- 102.Yates AR, Welty SE, Gest AL, Cua CL. Myocardial tissue Doppler changes in patients with bronchopulmonary dysplasia. J Pediatr 2008;152(6):766–770. [DOI] [PubMed]
- 103.Okumura K, Slorach C, Mroczek D, Dragulescu A, Mertens L, Redington AN, Friedberg MK. Right ventricular diastolic performance in children with pulmonary arterial hypertension associated with congenital heart disease: correlation of echocardiographic parameters with invasive reference standards by high-fidelity micromanometer catheter. Circ Cardiovasc Imaging 2014;7(3):491–501. [DOI] [PubMed]
- 104.Pye MP, Pringle SD, Cobbe SM. Reference values and reproducibility of Doppler echocardiography in the assessment of the tricuspid valve and right ventricular diastolic function in normal subjects. Am J Cardiol 1991;67(4):269–273. [DOI] [PubMed]
- 105.Nagaya N, Satoh T, Uematsu M, Okano Y, Kyotani S, Nakanishi N, Kunieda T. Shortening of Doppler-derived deceleration time of early diastolic transmitral flow in the presence of pulmonary hypertension through ventricular interaction. Am J Cardiol 1997;79(11):1502–1506. [DOI] [PubMed]
- 106.Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2(5):358–367. [DOI] [PubMed]
- 107.Chuang ML, Hibberd MG, Salton CJ, Beaudin RA, Riley MF, Parker RA, Douglas PS, Manning WJ. Importance of imaging method over imaging modality in noninvasive determination of left ventricular volumes and ejection fraction: assessment by two- and three-dimensional echocardiography and magnetic resonance imaging. J Am Coll Cardiol 2000;35(2):477–484. [DOI] [PubMed]
- 108.Koestenberger M, Nagel B, Ravekes W, Avian A, Burmas A, Grangl G, Cvirn G, Gamillscheg A. Reference values and calculation of z-scores of echocardiographic measurements of the normal pediatric right ventricle. Am J Cardiol 2014;114(10):1590–1598. [DOI] [PubMed]
- 109.Cantinotti M, Scalese M, Murzi B, Assanta N, Spadoni I, De Lucia V, Crocetti M, et al. Echocardiographic nomograms for chamber diameters and areas in Caucasian children. J Am Soc Echocardiogr 2014;27(12):1279–1292. [DOI] [PubMed]
- 110.Bustamante-Labarta M, Perrone S, de la Fuente RL, Stutzbach P, de la Hoz RP, Torino A, Favaloro R. Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension. J Am Soc Echocardiogr 2002;15(10):1160–1164. [DOI] [PubMed]
- 111.Habib G, Torbicki A. The role of echocardiography in the diagnosis and management of patients with pulmonary hypertension. Eur Respir Rev 2010;19(118):288–299. doi:10.1183/09059180.00008110. [DOI] [PMC free article] [PubMed]
- 112.Cioffi G, de Simone G, Mureddu G, Tarantini L, Stefenelli C. Right atrial size and function in patients with pulmonary hypertension associated with disorders of respiratory system or hypoxemia. Eur J Echocardiogr 2007;8(5):322–331. [DOI] [PubMed]
- 113.Brennan JM, Blair JE, Goonewardena S, Ronan A, Shah D, Vasaiwala S, Kirkpatrick JN, Spencer KT. Reappraisal of the use of inferior vena cava for estimating right atrial pressure. J Am Soc Echocardiogr 2007;20(7):857–861. [DOI] [PubMed]
- 114.Kircher BJ, Himelman RB, Schiller NB. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 1990;66(4):493–496. [DOI] [PubMed]
- 115.Beigel R, Cercek B, Luo H, Siegel RJ. Noninvasive evaluation of right atrial pressure. J Am Soc Echocardiogr 2013;26(9):1033–1042. [DOI] [PubMed]
- 116.Takahashi K, Inage A, Rebeyka IM, Ross DB, Thompson RB, Mackie AS, Smallhorn JF. Real-time 3-dimensional echocardiography provides new insight into mechanisms of tricuspid valve regurgitation in patients with hypoplastic left heart syndrome. Circulation 2009;120(12):1091–1098. [DOI] [PubMed]
- 117.Dragulescu A, Grosse-Wortmann L, Fackoury C, Riffle S, Waiss M, Jaeggi E, Yoo SJ, Friedberg MK, Mertens L. Echocardiographic assessment of right ventricular volumes after surgical repair of tetralogy of Fallot: clinical validation of a new echocardiographic method. J Am Soc Echocardiogr 2011;24(11):1191–1198. [DOI] [PubMed]
- 118.Renella P, Marx GR, Zhou J, Gauvreau K, Geva T. Feasibility and reproducibility of three-dimensional echocardiographic assessment of right ventricular size and function in pediatric patients. J Am Soc Echocardiogr 2014;27(8):903–910. [DOI] [PubMed]
- 119.Grewal J, Majdalany D, Syed I, Pellikka P, Warnes CA. Three-dimensional echocardiographic assessment of right ventricular volume and function in adult patients with congenital heart disease: comparison with magnetic resonance imaging. J Am Soc Echocardiogr 2010;23(2):127–133. [DOI] [PubMed]
- 120.Leibundgut G, Rohner A, Grize L, Bernheim A, Kessel-Schaefer A, Bremerich J, Zellweger M, Buser P, Handke M. Dynamic assessment of right ventricular volumes and function by real-time three-dimensional echocardiography: a comparison study with magnetic resonance imaging in 100 adult patients. J Am Soc Echocardiogr 2010;23(2):116–126. [DOI] [PubMed]
- 121.Van der Zwaan HB, Helbing WA, McGhie JS, Geleijnse ML, Luijnenburg SE, Roos-Hesselink JW, Meijboom FJ. Clinical value of realtime three-dimensional echocardiography for right ventricular quantification in congenital heart disease: validation with cardiac magnetic resonance imaging. J Am Soc Echocardiogr 2010;23(2):134–140. [DOI] [PubMed]
- 122.Kong D, Shu X, Dong L, Pan C, Cheng L, Yao H, Zhou D. Right ventricular regional systolic function and dyssynchrony in patients with pulmonary hypertension evaluated by three-dimensional echocardiography. J Am Soc Echocardiogr 2013;26(6):649–656. [DOI] [PubMed]
- 123.Tamborini G, Marsan NA, Gripari P, Maffessanti F, Brusoni D, Muratori M, Caiani EG, Fiorentini C, Pepi M. Reference values for right ventricular volumes and ejection fraction with real-time three-dimensional echocardiography: evaluation in a large series of normal subjects. J Am Soc Echocardiogr 2010;23(2):109–115. [DOI] [PubMed]
- 124.van der Zwaan HB, Geleijnse ML, McGhie JS, Boersma E, Helbing WA, Meijboom FJ, Roos-Hesselink JW. Right ventricular quantification in clinical practice: two-dimensional vs. three-dimensional echocardiography compared with cardiac magnetic resonance imaging. Eur J Echocardiogr 2011;12(9):656–664. [DOI] [PubMed]
- 125.Grapsa J, O’Regan DP, Pavlopoulos H, Durighel G, Dawson D, Nihoyannopoulos P. Right ventricular remodelling in pulmonary arterial hypertension with three-dimensional echocardiography: comparison with cardiac magnetic resonance imaging. Eur J Echocardiogr 2010;11(1):64–73. [DOI] [PubMed]
- 126.Grapsa J, Gibbs JS, Dawson D, Watson G, Patni R, Athanasiou T, Punjabi PP, Howard LS, Nihoyannopoulos P. Morphologic and functional remodeling of the right ventricle in pulmonary hypertension by real time three dimensional echocardiography. Am J Cardiol 2012;109(6):906–913. [DOI] [PubMed]
- 127.Lu X, Nadvoretskiy V, Bu L, Stolpen A, Ayres N, Pignatelli RH, Kovalchin JP, Grenier M, Klas B, Ge S. Accuracy and reproducibility of real-time three-dimensional echocardiography for assessment of right ventricular volumes and ejection fraction in children. J Am Soc Echocardiogr 2008;21(1):84–89. [DOI] [PubMed]
- 128.Friedberg MK, Su X, Tworetzky W, Soriano BD, Powell AJ, Marx GR. Validation of 3D echocardiographic assessment of left ventricular volumes, mass, and ejection fraction in neonates and infants with congenital heart disease: a comparison study with cardiac MRI. Circ Cardiovasc Imaging 2010;3(6):735–742. [DOI] [PubMed]
- 129.Khoo NS, Young A, Occleshaw C, Cowan B, Zeng IS, Gentles TL. Assessments of right ventricular volume and function using three-dimensional echocardiography in older children and adults with congenital heart disease: comparison with cardiac magnetic resonance imaging. J Am Soc Echocardiogr 2009;22(11):1279–1288. [DOI] [PubMed]
- 130.Li Y, Wang Y, Zhai Z, Guo X, Yang Y, Lu X. Real-time three-dimensional echocardiography to assess right ventricle function in patients with pulmonary hypertension. PLoS ONE 2015;10:e0129557. doi:10.1371/journal.pone.0129557. [DOI] [PMC free article] [PubMed]
- 131.Hansmann G, Hoeper MM. Registries for paediatric pulmonary hypertension. Eur Respir J 2013;42(3):580–583. [DOI] [PubMed]
- 132.Taylor C, Derrick G, McEwan A, Haworth S, Sury M. Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension. Br J Anaesth 2007;98(5):657–661. [DOI] [PubMed]
- 133.Baldi F, Fuso L, Arrighi E, Valente S. Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course. Ther Clin Risk Manag 2014;10:825–839. [DOI] [PMC free article] [PubMed]
- 134.Adatia I, Haworth S, Wegner M, Barst R, Ivy D, Stenmark K, Karkowsky A, Rosenzweig E, Aguilar C. Clinical trials in neonates and children: report of the pulmonary hypertension academic research consortium pediatric advisory committee. Pulm Circ 2013;3(1):252–266. [DOI] [PMC free article] [PubMed]
- 135.Vonk-Noordegraaf A, Westerhof N. Describing right ventricular function. Eur Respir J 2013;41(6):1419–1423. [DOI] [PubMed]
- 136.Vanderpool RR, Pinsky MR, Naeije R, Deible C, Kosaraju V, Bunner C, Mathier MA, Lacomis J, Champion HC, Simon MA. RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertension. Heart 2015;101(1):37–43. [DOI] [PMC free article] [PubMed]
- 137.Ernande L, Cottin V, Leroux PY, Girerd N, Huez S, Mulliez A, Bergerot C, et al. Right isovolumic contraction velocity predicts survival in pulmonary hypertension. J Am Soc Echocardiogr 2013;26(3):297–306. [DOI] [PubMed]